Phillips, Mark R. http://orcid.org/0000-0003-0923-261X
Chaudhary, Varun http://orcid.org/0000-0002-9988-4146
Article History
Received: 20 February 2022
Revised: 23 February 2022
Accepted: 23 February 2022
First Online: 8 March 2022
Competing interests
: MRP: nothing to disclose. VC: Advisory board member: Alcon, Roche, Bayer, Novartis; Grants: Bayer, Novartis—unrelated to this study.
Free to read: This content has been made available to all.